Numerai Gp LLC Evolus, Inc. Transaction History
Numerai Gp LLC
- $275 Billion
- Q2 2024
A detailed history of Numerai Gp LLC transactions in Evolus, Inc. stock. As of the latest transaction made, Numerai Gp LLC holds 51,001 shares of EOLS stock, worth $833,356. This represents 0.2% of its overall portfolio holdings.
Number of Shares
51,001
Previous 13,005
292.16%
Holding current value
$833,356
Previous $182 Million
203.93%
% of portfolio
0.2%
Previous 0.08%
Shares
2 transactions
Others Institutions Holding EOLS
# of Institutions
164Shares Held
49.1MCall Options Held
453KPut Options Held
14K-
Perceptive Advisors LLC New York, NY5.75MShares$94 Million1.81% of portfolio
-
Tang Capital Management LLC San Diego, CA4.85MShares$79.2 Million6.42% of portfolio
-
Black Rock Inc. New York, NY4.01MShares$65.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.99MShares$48.8 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.91MShares$47.6 Million2.11% of portfolio
About Evolus, Inc.
- Ticker EOLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 56,094,800
- Market Cap $917M
- Description
- Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...